isabelobrien, Author at European Medical Journal - Page 4 of 68

Handshake on globe backdrop

US tariff deal: what it means for UK pharma

Last week, the UK and US signed a zero tariff pharmaceuticals deal, but what will the deal deliver in the long term, and is all as it seems?

Month in pharma news, explained

Month in pharma news, explained – November 2025

In this monthly news roundup, we take a look back at top moments from the pharmaceutical industry. It’s time to reflect on November 2025.

Clinical trial participant

ABPI: UK falling behind on clinical trial recruitment

According to the body, patient participation in industry-sponsored trials has fallen by 25% between 2022/23 and 2024/25.

Carol Pitcher-Towner

Carol Pitcher-Towner on the gender health divide

This week, Isabel sits down with Carol Pitcher-Towner, Alnylam, to unpack the gender inequities that continue to shape modern healthcare.

Vaccine

Europe’s vaccine pipeline has 91 candidates in R&D

Crucially, 41% of these candidates target pathogens for which no vaccines or prophylactic monoclonal antibodies are currently registered.

Cartoon brain on green background

Epileptic seizure detection device to launch in Europe

A wearable device that can alert patients and caregivers minutes before a seizure occurs is set to launch across Europe.

Skyline of Spain

Pharma in Spain

Spain’s pharma sector is a hub for clinical trials, exports and digital innovation, but reforms remain key.

Doctor and patient discussing depression

AbbVie and BioMed X to study science of lost joy

The two companies have launched a collaborative research initiative to investigate anhedonia in depression, hoping to solve huge unmet needs.

Hanna Svanbäck

Hanna Svanbäck on shaping the future of Alzheimer’s care

Isabel is joined by Hanna Svanbäck, Executive Director for Neuroscience, Eli Lilly, for a deep dive into the current and future Alzheimer’s landscape.

Scotland sets £25bn target for life sciences by 2035

Scotland has announced a major new plan to grow its life sciences sector, aiming to boost economic growth and healthcare innovation.